Standard Dental Labs has acquired Dr. Tooth Dental Lab, and Sheen Dental and Hansen Incarnati are joining the company. SDL also plans to move outsourced production to Sarasota, according to the announcement.
Disclaimer: News content is based on public news sources and provided for information only. It does not constitute investment advice.
Standard Dental Labs (SDL) announced on October 2, 2026, that it has acquired Dr. Tooth Dental Lab. The announcement did not disclose the financial terms of the transaction. The acquisition brings Dr. Tooth Dental Lab under SDL's ownership, adding its operations to SDL's existing dental laboratory business. This move is part of SDL's broader effort to consolidate dental laboratory services under its brand. Such acquisitions are common in the dental lab sector as companies seek greater scale to invest in technology and manage costs.
In connection with the acquisition, Sheen Dental and Hansen Incarnati have joined SDL, according to the same announcement. The two entities are now part of SDL's network, which may allow for shared resources and coordinated production across locations. The exact roles of Sheen Dental and Hansen Incarnati within SDL were not specified in the announcement. Their integration could affect how dental practices that relied on these labs receive prosthetics and other services. Orders that were previously handled by these entities may be routed through SDL's central operations, though no timeline was provided.
SDL also plans to bring outsourced production to Sarasota, Florida, as part of the announcement. Dental laboratories frequently outsource certain stages of production, such as crown and bridge work or removable prosthetics, to third-party facilities. Bringing that production to Sarasota could mean that work previously handled elsewhere will now be completed at an SDL location in the city. This shift may affect turnaround times and shipping logistics for dental practices that send cases to SDL. The announcement did not specify which production lines would move or when the transition would occur.
The dental laboratory industry has seen ongoing consolidation as larger players acquire smaller labs to gain efficiencies and invest in digital dentistry tools like intraoral scanners and milling machines. SDL's acquisition of Dr. Tooth Dental Lab and the addition of Sheen Dental and Hansen Incarnati fit this pattern. For dental practices, such consolidation can mean fewer independent lab options but potentially more consistent quality control and centralized customer service. The move to bring production to Sarasota also reflects a broader trend of labs seeking to control their supply chains more directly. These changes may influence how dental practices choose laboratory partners in the future.
Standard Dental Labs announced that it has acquired Dr. Tooth Dental Lab. The company also said that Sheen Dental and Hansen Incarnati have joined SDL. Additionally, SDL stated plans to bring outsourced production to Sarasota.
Sheen Dental and Hansen Incarnati are joining SDL as part of the announcement. The two entities will become part of SDL's network. The specific terms of their integration were not disclosed in the announcement.
It means that production work currently outsourced by SDL will be relocated to Sarasota, Florida. Dental labs often outsource steps like crown and bridge fabrication to third-party facilities. Moving that work to Sarasota could change how and where those cases are completed.
Dental practices that send cases to Dr. Tooth Dental Lab, Sheen Dental, or Hansen Incarnati may see changes in how their orders are processed. If production is consolidated into SDL's Sarasota operations, turnaround times and shipping logistics could shift. The announcement did not provide a timeline or specific operational details.
Acquisition of Dr. Tooth Dental Lab
Sheen Dental and Hansen Incarnati Join SDL
Outsourced Production Moving to Sarasota
Industry Context and Implications
This article is rewritten from public news sources and further processed by AI. It is provided for information only and does not constitute investment advice — refer to the original source for the authoritative version.
The announcement did not include any financial terms for the acquisition. No purchase price, revenue figures, or other financial details were provided. This is common in private transactions where parties choose not to disclose deal values.
Dental laboratories face pressure to invest in digital workflows and maintain competitive pricing. Consolidation allows larger labs to spread those costs across more production volume. As a result, acquisitions of smaller labs by larger groups have been an ongoing trend in the industry.
